Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

1.

Determination of nadir growth hormone concentration cutoff in patients with acromegaly.

Bancos I, Algeciras-Schimnich A, Woodmansee WW, Cullinane AK, Donato LJ, Nippoldt TB, Natt N, Erickson D.

Endocr Pract. 2013 Nov-Dec;19(6):937-45. doi: 10.4158/EP12435.OR.

PMID:
23807518
[PubMed - indexed for MEDLINE]
2.

Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS.

Woodmansee WW, Zimmermann AG, Child CJ, Rong Q, Erfurth EM, Beck-Peccoz P, Blum WF, Robison LL; GeNeSIS and HypoCCS International Advisory Boards.

Eur J Endocrinol. 2013 Mar 15;168(4):565-73. doi: 10.1530/EJE-12-0967. Print 2013 Apr.

PMID:
23359434
[PubMed - indexed for MEDLINE]
Free Article
3.

Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients.

Hartman ML, Xu R, Crowe BJ, Robison LL, Erfurth EM, Kleinberg DL, Zimmermann AG, Woodmansee WW, Cutler GB Jr, Chipman JJ, Melmed S; International HypoCCS Advisory Board.

J Clin Endocrinol Metab. 2013 Mar;98(3):980-8. doi: 10.1210/jc.2012-2684. Epub 2013 Jan 23.

PMID:
23345098
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Lanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry.

Salvatori R, Woodmansee WW, Molitch M, Gordon MB, Lomax KG.

Pituitary. 2014 Feb;17(1):13-21. doi: 10.1007/s11102-012-0460-2.

PMID:
23314980
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Refractory pituitary granulomatosis with polyangiitis (Wegener's) treated with rituximab.

Hughes J, Barkhoudarian G, Ciarlini P, Laws ER, Mody E, Inzucchi SE, Woodmansee WW.

Endocr Pract. 2013 Jan-Feb;19(1):e1-7. doi: 10.4158/EP12181.CR.

PMID:
23186961
[PubMed - indexed for MEDLINE]
Free Article
6.

The postoperative cortisol stress response following transsphenoidal pituitary surgery: a potential screening method for assessing preserved pituitary function.

Zada G, Tirosh A, Huang AP, Laws ER, Woodmansee WW.

Pituitary. 2013 Sep;16(3):319-25. doi: 10.1007/s11102-012-0423-7.

PMID:
22915289
[PubMed - indexed for MEDLINE]
7.

Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study.

Child CJ, Zimmermann AG, Woodmansee WW, Green DM, Li JJ, Jung H, Erfurth EM, Robison LL; HypoCCS International Advisory Board.

Eur J Endocrinol. 2011 Aug;165(2):217-23. doi: 10.1530/EJE-11-0286. Epub 2011 Jun 6.

PMID:
21646285
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Prevalence and incidence of diabetes mellitus in adult patients on growth hormone replacement for growth hormone deficiency: a surveillance database analysis.

Attanasio AF, Jung H, Mo D, Chanson P, Bouillon R, Ho KK, Lamberts SW, Clemmons DR; HypoCCS International Advisory Board.

J Clin Endocrinol Metab. 2011 Jul;96(7):2255-61. doi: 10.1210/jc.2011-0448. Epub 2011 May 4.

PMID:
21543424
[PubMed - indexed for MEDLINE]
9.

Atypical pituitary adenomas: incidence, clinical characteristics, and implications.

Zada G, Woodmansee WW, Ramkissoon S, Amadio J, Nose V, Laws ER Jr.

J Neurosurg. 2011 Feb;114(2):336-44. doi: 10.3171/2010.8.JNS10290. Epub 2010 Sep 24.

PMID:
20868211
[PubMed - indexed for MEDLINE]
10.

Cushing's disease and idiopathic intracranial hypertension: case report and review of underlying pathophysiological mechanisms.

Zada G, Tirosh A, Kaiser UB, Laws ER, Woodmansee WW.

J Clin Endocrinol Metab. 2010 Nov;95(11):4850-4. doi: 10.1210/jc.2010-0896. Epub 2010 Aug 25. Review.

PMID:
20739379
[PubMed - indexed for MEDLINE]
11.

Perioperative management of patients undergoing transsphenoidal pituitary surgery.

Zada G, Woodmansee WW, Iuliano S, Laws ER.

Asian J Neurosurg. 2010 Jan;5(1):1-6.

PMID:
22028737
[PubMed]
Free PMC Article
12.

Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing's disease or non-functioning pituitary adenoma.

Webb SM, Mo D, Lamberts SW, Melmed S, Cavagnini F, Pecori Giraldi F, Strasburger CJ, Zimmermann AG, Woodmansee WW; International HypoCCS Advisory Board.

J Clin Endocrinol Metab. 2010 Feb;95(2):630-8. doi: 10.1210/jc.2009-0806. Epub 2009 Dec 18.

PMID:
20022992
[PubMed - indexed for MEDLINE]
13.

Occurrence of impaired fasting glucose in GH-deficient adults receiving GH replacement compared with untreated subjects.

Woodmansee WW, Hartman ML, Lamberts SW, Zagar AJ, Clemmons DR; International HypoCCS Advisory Board.

Clin Endocrinol (Oxf). 2010 Jan;72(1):59-69. doi: 10.1111/j.1365-2265.2009.03612.x. Epub 2009 May 4.

PMID:
19438908
[PubMed - indexed for MEDLINE]
14.

Single-dose rexinoid rapidly and specifically suppresses serum thyrotropin in normal subjects.

Golden WM, Weber KB, Hernandez TL, Sherman SI, Woodmansee WW, Haugen BR.

J Clin Endocrinol Metab. 2007 Jan;92(1):124-30. Epub 2006 Oct 24.

PMID:
17062760
[PubMed - indexed for MEDLINE]
15.

Pituitary tumors arising from glycoprotein hormone alpha-subunit-deficient mice contain transcription factors and receptors present in thyrotropes.

Sarapura VD, Wood WM, Woodmansee WW, Haakinson DJ, Dowding JM, Gordon DF, Ridgway EC.

Pituitary. 2006;9(1):11-8.

PMID:
16703404
[PubMed - indexed for MEDLINE]
16.

The proliferative status of thyrotropes is dependent on modulation of specific cell cycle regulators by thyroid hormone.

Woodmansee WW, Kerr JM, Tucker EA, Mitchell JR, Haakinson DJ, Gordon DF, Ridgway EC, Wood WM.

Endocrinology. 2006 Jan;147(1):272-82. Epub 2005 Oct 13.

PMID:
16223861
[PubMed - indexed for MEDLINE]
17.

Growth arrest of thyrotropic tumors by thyroid hormone is correlated with novel changes in Wnt-10A.

Kerr JM, Gordon DF, Woodmansee WW, Sarapura VD, Ridgway EC, Wood WM.

Mol Cell Endocrinol. 2005 Jun 30;238(1-2):57-67.

PMID:
15896901
[PubMed - indexed for MEDLINE]
18.

Silent corticotroph adenomas: further clinical and pathological observations.

Lopez JA, Kleinschmidt-Demasters Bk Bk, Sze CI, Woodmansee WW, Lillehei KO.

Hum Pathol. 2004 Sep;35(9):1137-47.

PMID:
15343517
[PubMed - indexed for MEDLINE]
19.

Uses for recombinant human TSH in patients with thyroid cancer and nodular goiter.

Woodmansee WW, Haugen BR.

Clin Endocrinol (Oxf). 2004 Aug;61(2):163-73. Review.

PMID:
15272910
[PubMed - indexed for MEDLINE]
20.

The management of subclinical hyperthyroidism by thyroid specialists.

McDermott MT, Woodmansee WW, Haugen BR, Smart A, Ridgway EC.

Thyroid. 2003 Dec;13(12):1133-9.

PMID:
14751034
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk